Series D Financing
-
Biologics
InGeneron Extends Series D Financing to $43 Million to Bring Regenerative Cell Therapy into the Clinic
June 11, 2019 HOUSTON–(BUSINESS WIRE)–InGeneron, Inc., a clinical stage regenerative medicine and cell therapy company, announced today the extension of…
Read More »